Related references
Note: Only part of the references are listed.Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes
Shridhara Alva et al.
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2022)
Residual beta cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia
Rose A. Gubitosi-Klug et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Non-invasive and minimally invasive glucose monitoring devices: a systematic review and meta-analysis on diagnostic accuracy of hypoglycaemia detection
Nicole Lindner et al.
SYSTEMATIC REVIEWS (2021)
Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial
Johnny Ludvigsson et al.
DIABETES CARE (2021)
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Manuela Battaglia et al.
DIABETES CARE (2020)
Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes
Ulf Hannelius et al.
DIABETOLOGIA (2020)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study
Marcus Lind et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
cgmanalysis: An R package for descriptive analysis of continuous glucose monitor data
Tim Vigers et al.
PLOS ONE (2019)
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Roy W. Beck et al.
DIABETES CARE (2019)
The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes
Robert A. Vigersky et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
The challenge of modulating β-cell autoimmunity in type 1 diabetes
Mark A. Atkinson et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
Jingyi Lu et al.
DIABETES CARE (2018)
Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
Richard M. Bergenstal et al.
DIABETES CARE (2018)
Glycemic Variability: How Do We Measure It and Why Is It Important?
Sunghwan Suh et al.
DIABETES & METABOLISM JOURNAL (2015)
Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden)
Maria Nordwall et al.
DIABETES CARE (2015)
Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
John M. Lachin et al.
DIABETES (2014)
Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability Data
Yongming Qu et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2012)
Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study
Hillary A. Keenan et al.
DIABETES (2010)
β-cell function and the development of diabetes-related complications in the diabetes control and complications trial
MW Steffes et al.
DIABETES CARE (2003)
Share Paper
